73 related articles for article (PubMed ID: 8651997)
1. [Stromal tumors of the digestive tract. Prognostic evaluation of a series of 36 cases].
Ghnassia JP; Wagner M; Velten M
Ann Pathol; 1996; 16(1):27-32. PubMed ID: 8651997
[TBL] [Abstract][Full Text] [Related]
2. Proliferating cell nuclear antigen immunoreactivity and prognosis of gastrointestinal stromal tumors.
Franquemont DW; Frierson HF
Mod Pathol; 1995 Jun; 8(5):473-7. PubMed ID: 7675763
[TBL] [Abstract][Full Text] [Related]
3. Stromal tumors of the stomach: prognostic value of the PCNA index.
Ray R; Tahan SR; Andrews C; Goldman H
Mod Pathol; 1994 Jan; 7(1):26-30. PubMed ID: 7909152
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic significance of proliferation markers in hepatocellular carcinoma (HCC)].
Ebelt J; Neid M; Tannapfel A; Witzigmann H; Hauss J; Köckerling F; Wittekind C
Zentralbl Chir; 2000; 125(7):597-601. PubMed ID: 10960968
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic features, cellular differentiation, PCNA and P53 expressions in gastrointestinal stromal tumors.
Can B; Sökmensüer C
Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxliii-ccxlviii. PubMed ID: 15244191
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors in uterine carcinosarcoma: a clinicopathologic study of 25 patients.
Iwasa Y; Haga H; Konishi I; Kobashi Y; Higuchi K; Katsuyama E; Minamiguchi S; Yamabe H
Cancer; 1998 Feb; 82(3):512-9. PubMed ID: 9452269
[TBL] [Abstract][Full Text] [Related]
7. Stromal tumors of the digestive tract. Prognostic value of mitotic index.
Moral Moral G; Gil Piedra F; Velasco Osés A; Seco Gil JL; de la Plaza Galindo M; Santamaría García JL
Rev Esp Enferm Dig; 1998 May; 90(5):335-44. PubMed ID: 9656753
[TBL] [Abstract][Full Text] [Related]
8. The expression and prognostic role of hepatoma-derived growth factor in colorectal stromal tumors.
Hu TH; Lin JW; Chen HH; Liu LF; Chuah SK; Tai MH
Dis Colon Rectum; 2009 Feb; 52(2):319-26. PubMed ID: 19279430
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis and proliferation in relation to histopathological variables and prognosis in hepatocellular carcinoma.
Tannapfel A; Geissler F; Köckerling F; Katalinic A; Hauss J; Wittekind C
J Pathol; 1999 Mar; 187(4):439-45. PubMed ID: 10398104
[TBL] [Abstract][Full Text] [Related]
10. The abnormalities in the p53/p21WAF1 pathway have a significant role in the pathogenesis and progression of gastrointestinal stromal tumors.
Chou YP; Lin JW; Wang CC; Chiu YC; Huang CC; Chuah SK; Tai MH; Yi LN; Lee CM; Changchien CS; Hu TH
Oncol Rep; 2008 Jan; 19(1):49-56. PubMed ID: 18097575
[TBL] [Abstract][Full Text] [Related]
11. Survival and prognostic factors analysis in surgically resected gastrointestinal stromal tumor patients.
Song Z; Wang JL; Pan YL; Tao DY; Gan MF; Huang KE
Hepatogastroenterology; 2009; 56(89):149-53. PubMed ID: 19453047
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of prognostic indicators for sarcomas of the soft parts and the viscerae.
Rudolph P; Bonichon F; Gloeckner K; Collin F; Chassevent A; Schmidt D; Coindre JM; Parwaresch R; Klöppel G
Verh Dtsch Ges Pathol; 1998; 82():246-52. PubMed ID: 10095442
[TBL] [Abstract][Full Text] [Related]
13. Prognostic values of stromal proportion and PCNA, Ki-67, and p53 proteins in patients with resected adenocarcinoma of the lung.
Demarchi LM; Reis MM; Palomino SA; Farhat C; Takagaki TY; Beyruti R; Saldiva PH; Capelozzi VL
Mod Pathol; 2000 May; 13(5):511-20. PubMed ID: 10824922
[TBL] [Abstract][Full Text] [Related]
14. [New histopathologic data of prognostic value in extra-adrenal paragangliomas. Study of 9 cases].
García Rojo M; Martínez García C; Gamallo Amat C; Patrón Romero M
Med Clin (Barc); 1993 Sep; 101(9):327-32. PubMed ID: 8105157
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma.
Belessi CJ; Parasi AS; Manioudaki HS; Laoutaris NP; Legakis NC; Peros GT; Androulakis GA
J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009
[TBL] [Abstract][Full Text] [Related]
16. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
Oyama T; Osaki T; Nose N; Ichiki Y; Inoue M; Imoto H; Yoshimatsu T; Kodate M; Uramoto H; Mizoue T; Yano K; Yasumoto K
Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in malignant gastrointestinal stromal tumors.
Muro-Cacho CA; Cantor AB; Morgan M
Ann Clin Lab Sci; 2000 Jul; 30(3):239-47. PubMed ID: 10945563
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
[TBL] [Abstract][Full Text] [Related]
19. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
Crucitti A; Masetti R; Breccia C; Coppola R; Magistrelli P; Nuzzo G; Maggiano N; Picciocchi A
Hepatogastroenterology; 1999; 46(26):1187-91. PubMed ID: 10370689
[TBL] [Abstract][Full Text] [Related]
20. [Adrenal cortical tumors. Prognostic evaluation of a series of 12 cases using anti-PCNA antibodies].
Ghnassia JP; Wagner M; Gasser B; Walter PR
Ann Pathol; 1993; 13(5):312-6. PubMed ID: 7906124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
